Skip to main content
Equibles
FLGT logo

FLGT · Fulgent Genetics, Inc.

Track FLGT — free

Use FLGT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about FLGT

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$18.56 -0.09 (-0.48%) At close · Aug 14
Market Cap
$510.68M
Shares
27.52M

Fulgent Genetics, Inc. Earnings Call Transcripts

Every quarterly earnings call for Fulgent Genetics, Inc. (FLGT) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼53.6% $105.66M $1.72M '22 Q3 22-11-07 ▼73.1% $67.70M −$23.83M '22 Q4 23-02-28 ▼79.3% $66.17M −$15.34M '23 Q1 23-05-05 ▼45.9% $67.85M −$11.23M '23 Q2 23-08-04 ▼19.8% $84.69M −$13.11M '23 Q3 23-11-03 ▲4.1% $70.50M −$128.15M '23 Q4 24-02-28 ▼2.5% $64.48M −$13.46M '24 Q1 24-05-03 ▲4.7% $71.03M −$8.71M '24 Q2 24-08-02 ▼15.3% $71.74M −$14.65M '24 Q3 24-11-08 ▲8.1% $76.21M −$5.89M '24 Q4 25-02-28 ▲13.9% $73.46M −$11.53M '25 Q1 25-05-02 ▲15.2% $81.80M −$18.96M '25 Q2 25-08-01 ▲17.2% $84.07M −$6.61M '25 Q3 25-11-07 ▲9.3% $83.34M −$23.42M '25 Q4 26-02-27 ▼3.2% $71.14M −$24.83M '26 Q1 26-05-01 LATEST ▲4.4% $85.39M −$29.53M '26 Q2 26-07-30
Earnings call
FY26 · Q2
2026-07-30
Q2 2026 Fulgent Genetics Earnings Conference Call
Cautious tone Revised revenue and EPS guidance M&A integration Cash position and share repurchases
Revenue
$85.39M
▲ 4.4% YoY
Gross margin
30.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-01
Fulgent Genetics, Inc. Q1 FY2026 Earnings Call
Positive tone Therapeutic development / FID-007 Bako and StrataDx acquisition Whole genome and rare disease testing
Revenue
$71.14M
▼ 3.2% YoY
Gross margin
30.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-27
Fulgent Genetics, Inc. Q4 FY2025 Earnings Call
Positive tone Bako (anatomic pathology) acquisition Largest customer in-housing Full-year and Q4 revenue results
Revenue
$83.34M*
▲ 9.3% YoY
Gross margin
39.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-07
Fulgent Genetics, Inc. Q3 FY2025 Earnings Call
Revenue
$84.07M
▲ 17.2% YoY
Gross margin
42.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-01
Fulgent Genetics, Inc. Q2 FY2025 Earnings Call
Revenue
$81.80M
▲ 15.2% YoY
Gross margin
42.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-02
Fulgent Genetics, Inc. Q1 FY2025 Earnings Call
Revenue
$73.46M
▲ 13.9% YoY
Gross margin
38.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-28
Fulgent Genetics, Inc. Q4 FY2024 Earnings Call
Revenue
$76.21M*
▲ 8.1% YoY
Gross margin
41.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-08
Fulgent Genetics, Inc. Q3 FY2024 Earnings Call
Revenue
$71.74M
▼ 15.3% YoY
Gross margin
37.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-02
Fulgent Genetics, Inc. Q2 FY2024 Earnings Call
Revenue
$71.03M
▲ 4.7% YoY
Gross margin
37.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-03
Fulgent Genetics, Inc. Q1 FY2024 Earnings Call
Revenue
$64.48M
▼ 2.5% YoY
Gross margin
34.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-28
Fulgent Genetics, Inc. Q4 FY2023 Earnings Call
Revenue
$70.50M*
▲ 4.1% YoY
Gross margin
35.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-03
Fulgent Genetics, Inc. Q3 FY2023 Earnings Call
Revenue
$84.69M
▼ 19.8% YoY
Gross margin
47.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-04
Fulgent Genetics, Inc. Q2 FY2023 Earnings Call
Revenue
$67.85M
▼ 45.9% YoY
Gross margin
30.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-05
Fulgent Genetics, Inc. Q1 FY2023 Earnings Call
Revenue
$66.17M
▼ 79.3% YoY
Gross margin
28.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
Fulgent Genetics, Inc. Q4 FY2022 Earnings Call
Revenue
$67.70M
▼ 73.1% YoY
Gross margin
19.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-07
Fulgent Genetics, Inc. Q3 FY2022 Earnings Call
Revenue
$105.66M
▼ 53.6% YoY
Gross margin
43.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Fulgent Genetics, Inc. Q2 FY2022 Earnings Call
Revenue
$125.34M
▼ 18.4% YoY
Gross margin
52.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-04-18
Fulgent Genetics, Inc. Q1 FY2022 Earnings Call
Revenue
$320.27M
▼ 10.9% YoY
Gross margin
75.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Fulgent Genetics, Inc. Q4 FY2021 Earnings Call
Revenue
$251.67M
▼ 14.7% YoY
Gross margin
75.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-09
Fulgent Genetics, Inc. Q3 FY2021 Earnings Call
Revenue
$227.87M
▲ 124% YoY
Gross margin
80.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-09
Fulgent Genetics, Inc. Q2 FY2021 Earnings Call
Revenue
$153.62M
▲ 789.8% YoY
Gross margin
76.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Fulgent Genetics, Inc. Q1 FY2021 Earnings Call
Revenue
$359.43M
▲ 4536% YoY
Gross margin
79.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-04
Fulgent Genetics, Inc. Q4 FY2020 Earnings Call
Revenue
$294.98M
▲ 3417.1% YoY
Gross margin
82.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Fulgent Genetics, Inc. Q3 FY2020 Earnings Call
Revenue
$101.72M
▲ 883% YoY
Gross margin
74.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-04
Fulgent Genetics, Inc. Q2 FY2020 Earnings Call
Revenue
$17.27M
▲ 105% YoY
Gross margin
55.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-04
Fulgent Genetics, Inc. Q1 FY2020 Earnings Call
Revenue
$7.75M
▲ 44.4% YoY
Gross margin
47.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-10
Fulgent Genetics, Inc. Q4 FY2019 Earnings Call
Revenue
$8.39M
▲ 47.8% YoY
Gross margin
56.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–27 of 27 earnings calls
Key facts CIK 1674930 CUSIP 359664109 13F (30d) 135 filings 131 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)